Table 1 Group classifications for gene expression analyses.
From: Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?
Gene Expression Analysis | |||
|---|---|---|---|
Number of individuals | |||
CDR Groups | Dementia Severity | Hippocampus | Area 20 |
0 | No dementia | 18 | 18 |
0.5 | Questionable dementia | 13 | 13 |
1 | Mild dementia | 9 | 8 |
2 | Moderate dementia | 9 | 13 |
3 | Severe dementia | 12 | 18 |
4-5 | Very severe/terminal dementia | 12 | 18 |
Braak Groups | Braak stages | ||
0 | None | 7 | 9 |
I | Mild transentorhinal | 8 | 9 |
II | Severe transentorhinal | 15 | 16 |
III | Limbic | 10 | 12 |
IV | Limbic/Hippocampal CA1 | 8 | 8 |
V | Isocortical | 12 | 15 |
VI | Isocortical/Primary sensory areas | 13 | 19 |
NP Density Groups | Plaques (number/mm 2 ) | ||
0 | 0 | 24 | 26 |
1 | 1-5 | 10 | 13 |
2 | 6-10 | 20 | 23 |
3 | 11-20 | 14* | 14 |
4 | 21 and more | 5* | 12 |